Quantifi Releases Support for Calculating the Effect of Funding Costs on OTC Valuation using Funding Valuation Adjustments (FVA)

LONDON & NEW YORK--(BUSINESS WIRE)-- Quantifi, a leading provider of analytics and risk management solutions to the global OTC markets, today announced first-to-market support for Funding Valuation Adjustments (FVA) as part of its latest Version 10.2 release. This enhancement allows firms to accurately measure the effect of funding costs on the valuation and risk management of OTC derivative portfolios.

The increasing cost of capital under new financial regulations including Basel III, MiFID II and Dodd-Frank are driving the need to more accurately value the risks of OTC derivatives. The rapidly evolving market best practice now includes calculating FVA along with Credit Valuation Adjustments (CVA) to measure the impact of funding and counterparty risk.

Rohan Douglas, CEO of Quantifi, comments, “The cost of funding has become a significant topic for financial institutions as it is regarded as a key component in analysing the exposures and profitability of a trade. FVA is the latest market innovation that has rapidly become the standard for measuring this cost. Our support for FVA continues a long track record of partnering with clients to deliver solutions that give them a competitive edge by more accurately valuing and measuring their risks.”

Using Quantifi Counterparty Risk, clients now have the ability to measure both the value and sensitivity of FVA at a trade and a portfolio level. Quantifi Counterparty Risk, a next generation counterparty risk system, is designed from the ground up to uniquely satisfy the rapidly evolving needs of regulatory compliance, corporate reporting and CVA trading. Incorporating the market’s most advanced, high performance American Monte Carlo engine combined with scalable grid computing, Quantifi Counterparty Risk supports even the largest, most complex portfolios.

Dmitry Pugachevsky, Director of Research at Quantifi, says, “FVA is the latest in a triad of valuation adjustments (CVA, DVA, FVA) which has to be taken into account when profitability of the trade is estimated. Unlike CVA, it is the cost which can’t be passed to the counterparty, therefore knowing it is imperative for successful management of the trading book. Value of the FVA charge is proportional to the funding cost of the bank, therefore banks with higher funding spread (i.e. worse credit) end up losing trades and become less competitive.”

About Quantifi

Quantifi is a leading provider of analytics, trading and risk management solutions for the global OTC markets. Our award-winning suite of integrated pre and post-trade solutions allow market participants to better value, trade and risk manage their exposures and respond more effectively to changing market conditions.

Founded in 2002, Quantifi is trusted by the world’s most sophisticated financial institutions including five of the six largest global banks, two of the three largest asset managers, leading hedge funds, insurance companies, pension funds and other financial institutions across 15 countries.

For further information, please visit www.quantifisolutions.com.

CognitoBinna Kim/Angela Byrne, +1-646-395-6300
quantifi@cognitomedia.com

Source: Quantifi